Hitoshi Nakayama

Dr. Hitoshi Nakayama

Juntendo University Faculty of Health Care and Nursing, Juntendo University Graduate School of Health Care and Nursing, Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2011 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
KHKuniaki Hirose
Kuniaki Hirose
KIKazuhisa Iwabuchi
Kazuhisa Iwabuchi
KSKazunori Shimada
Kazunori Shimada
TKTakashi Kiyanagi
Takashi Kiyanagi
CIChihiro Iwahara
Chihiro Iwahara
HDHiroyuki Daida
Hiroyuki Daida
Background: Oxidized low-density lipoprotein (oxLDL) uptake by macrophages plays an important role in foam cell formation. It has been suggested the presence of heterogeneous subsets of macrophage, such as M1 and M2, in human atherosclerotic lesions. To evaluate which types of macrophages contribute to atherogenesis, we performed cDNA microarray analysis to determine oxLDL-induced transcriptional alterations of each subset of macrophages.Results: Human monocyte-derived macrophages were polarized toward the M1 or M2 subset, followed by treatment with oxLDL. Then gene expression levels during oxLDL treatment in each subset of macrophages were evaluated by cDNA microarray analysis and quantitative real-time RT-PCR. In terms of high-ranking upregulated genes and functional ontologies, the alterations during oxLDL treatment in M2 macrophages were similar to those in nonpolarized macrophages (M0). Molecular network analysis showed that most of the molecules in the oxLDL-induced highest scoring molecular network of M1 macrophages were directly or indirectly related to transforming growth factor (TGF)-β1. Hierarchical cluster analysis revealed commonly upregulated genes in all subset of macrophages, some of which contained antioxidant response elements (ARE) in their promoter regions. A cluster of genes that were specifically upregulated in M1 macrophages included those encoding molecules related to nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB) signaling pathway. Quantitative real-time RT-PCR showed that the gene expression of interleukin (IL)-8 after oxLDL treatment in M2 macrophages was markedly lower than those in M0 and M1 cells.HMOX1gene expression levels were almost the same in all 3 subsets of macrophages even after oxLDL treatment.Conclusions: The present study demonstrated transcriptional alterations in polarized macrophages during oxLDL treatment. The data suggested that oxLDL uptake may affect TGF-β1- and NF-κB-mediated functions of M1 macrophages, but not those of M0 or M2 macrophages. It is likely that M1 macrophages characteristically respond to oxLDL.

17 March 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
TKTsukasa Kochiyama
Tsukasa Kochiyama
XLXiaojia Li
Xiaojia Li
HNHitoshi Nakayama
Hitoshi Nakayama
MKMadoka Kage
Madoka Kage
YYYui Yamane
Yui Yamane
EIEiichi Inada
Eiichi Inada
Macrophages are key immune system cells involved in inflammatory processes. Classically activated (M1) macrophages are characterized by strong antimicrobicidal properties, whereas alternatively activated (M2) macrophages are involved in wound healing. Severe inflammation can induce postoperative complications during the perioperative period. Invasive surgical procedures induce polarization to M1 macrophages and associated complications. As perioperative management, it is an important strategy to regulate polarization and functions of macrophages during inflammatory processes. Although propofol has been found to exhibit anti-inflammatory activities in monocytes and macrophages, it is unclear whether propofol regulates the functions of M1 and M2 macrophages during inflammatory processes. This study therefore investigated the effects of propofol on human macrophage polarization. During M1 polarization, propofol suppressed the production of IL-6 and IL-1β but did not affect TNF-α production. In contrast, propofol did not affect the gene expression of M2 markers, such as IL-10, TGF-β, and CD206, during M2 polarization. Propofol was similar to the GABAA agonist muscimol in inducing nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) and inhibiting IL-6 and IL-1β, but not TNF-α, production. Knockdown of Nrf2 using siRNA significantly reduced the effect of propofol on IL-6 and IL-1β production. These results suggest that propofol prevents inflammatory responses during polarization of human M1 macrophages by suppressing the expression of IL-6 and IL-1β through the GABAA receptor and the Nrf2-mediated signal transduction pathway.

26 March 1998 in Nephron
Verified
Journal Article
Closed access
PDF file
HNHitoshi Nakayama
Hitoshi Nakayama
TOT. Oite
T. Oite
HKH. Kawachi
H. Kawachi
TMT. Morioka
T. Morioka
HKH. Kobayashi
H. Kobayashi
FSF. Shimizu
F. Shimizu
The pathophysiological role of the Thy-1.1 molecule expressed on rat mesangial cells with regard to mesangial cell dysfunction and injury remains unknown. The mechanism of Thy-1.1-associated injury has now been investigated with two monoclonal antibodies, 1-22-3 and OX7, that recognize different epitopes of Thy-1.1. Mesangiolysis and mesangial cell proliferation were more marked in rats injected with 1-22-3 than in those treated with OX7. Immunostaining for rat complement component C3 and also C9 was similar in the kidneys of rats 1 h after injection of either antibody. Alpha smooth muscle actin was first detected 3 days after injection of 1-22-3 and peaked on day 5; type I collagen staining showed a mesangial pattern on days 5 and 10. The staining for alpha smooth muscle actin and type I collagen was less intense in OX7-treated rats than in the 1-22-3-injected rats. The amounts of mRNAs encoding collagen types I and III peaked 5 days after injection of 1-22-3 and 10 days after injection of OX7. Rats injected with 1-22-3 developed proteinuria that was already marked on day 1 and peaked at 150 mg/day on day 3, whereas OX7 induced a low grade of proteinuria with large interindividual variability on day 3. Immunostaining for rat C3 in the normal rat kidneys, incubated in vitro with 1-22-3 or OX7 followed by incubation with normal rat fresh serum as a complement source, as well as the levels of serum complement activity, CH50, 30 min after injection of 1-22-3 or OX7 were similar, suggesting that the difference in the nephritogenicity of these two antibodies is not attributable to a difference in their complement-fixing activities, but rather may result from the difference in epitope specificities. The epitope recognized by 1-22-3 thus appears to be important in the initiation and progression of antibody-induced nephritis.

Verified
Journal Article
Open access
PDF file
NYNoriko Yokoyama
Noriko Yokoyama
KHKei Hanafusa
Kei Hanafusa
THTomomi Hotta
Tomomi Hotta
EOEriko Oshima
Eriko Oshima
KIKazuhisa Iwabuchi
Kazuhisa Iwabuchi
HNHitoshi Nakayama
Hitoshi Nakayama
Glycosphingolipids (GSLs), together with cholesterol, sphingomyelin (SM), and glycosylphosphatidylinositol (GPI)-anchored and membrane-associated signal transduction molecules, form GSL-enriched microdomains. These specialized microdomains interact in a cis manner with various immune receptors, affecting immune receptor-mediated signaling. This, in turn, results in the regulation of a broad range of immunological functions, including phagocytosis, cytokine production, antigen presentation and apoptosis. In addition, GSLs alone can regulate immunological functions by acting as ligands for immune receptors, and exogenous GSLs can alter the organization of microdomains and microdomain-associated signaling. Many pathogens, including viruses, bacteria and fungi, enter host cells by binding to GSL-enriched microdomains. Intracellular pathogens survive inside phagocytes by manipulating intracellular microdomain-driven signaling and/or sphingolipid metabolism pathways. This review describes the mechanisms by which GSL-enriched microdomains regulate immune signaling.

16 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
BUBaasanjav Uranbileg
Baasanjav Uranbileg
HIHideaki Isago
Hideaki Isago
HNHitoshi Nakayama
Hitoshi Nakayama
DJDaisuke Jubishi
Daisuke Jubishi
KOKoh Okamoto
Koh Okamoto
MKMakoto Kurano
Makoto Kurano
The COVID‐19 pandemic, caused by SARS‐CoV‐2, has had a significant worldwide impact, affecting millions of people. COVID‐19 is characterized by a heterogenous clinical phenotype, potentially involving hyperinflammation and prolonged tissue damage, although the exact underlying mechanisms are yet to be fully understood. Sphingolipid metabolites, which govern cell survival and proliferation, have emerged as key players in inflammatory signaling and cytokine responses. Given the complex metabolic pathway of sphingolipids, this study aimed to understand their potential role in the pathogenesis of COVID‐19. We conducted a comprehensive examination of sphingolipid modulations across groups classified based on disease severity, incorporating a time‐course in serum and urine samples. Several sphingolipids, including sphingosine, lactosylceramide, and hexosylceramide, emerged as promising indicators of COVID‐19 severity, as validated by correlation analyses conducted on both serum and urine samples. Other sphingolipids, such as sphingosine 1‐phosphate, ceramides, and deoxy‐dihydroceramides, decreased in both COVID‐19 patients and individuals with non‐COVID infectious diseases. This suggests that these sphingolipids are not specifically associated with COVID‐19 but rather with pathological conditions caused by infectious diseases. Our analysis of urine samples revealed elevated levels of various sphingolipids, with changes dependent on disease severity, potentially highlighting the acute kidney injury associated with COVID‐19. This study illuminates the intricate relationship between disturbed sphingolipid metabolism, COVID‐19 severity, and clinical factors. These findings provide valuable insights into the broader landscape of inflammatory diseases.

1 April 2000 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
HNHitoshi Nakayama
Hitoshi Nakayama
SUSatoshi Ueno
Satoshi Ueno
TIToshihiko Ikeuchi
Toshihiko Ikeuchi
HHHiroshi Hatanaka
Hiroshi Hatanaka
To investigate the effects of nerve growth factor (NGF) and cyclic AMP (cAMP) on the level of the nicotinic acetylcholine receptor subunit α3 mRNA, we used PC12h cells, PC12 cells expressing dominant‐negative Ras protein, and the parental PC12 cells. PC12h cells have NGF‐responsive tyrosine hydroxylase activity. Expression of dominant‐negative Ras protein prevents the signaling through the Ras‐mitogen‐activated protein kinase cascade. The morphological changes of the parental PC12 cells in response to NGF and 8‐(4‐chlorophenylthio)adenosine 3′,5′‐cyclic monophosphate (CPTcAMP), a cell‐penetrating cAMP analogue, were similar to those of PC12h cells. NGF up‐regulated the α3 mRNA level in PC12h cells and down‐regulated the α3 mRNA level in the parental PC12 cells. Expression of dominant‐negative Ras protein and an inhibitor of mitogen‐activated protein kinase kinase inhibited the effects of NGF on α3 mRNA level. CPTcAMP down‐regulated the α3 mRNA level in all three PC12 cell lines. An inhibitor of protein kinase A inhibited the CPTcAMP‐induced down‐regulation of α3 mRNA. The α3 mRNA down‐regulation required prolonged treatment with CPTcAMP even after cAMP response element binding protein phosphorylation was decreased. Membrane depolarization with high K+ had no effect on the α3 mRNA level in PC12h cells. Based on these results, we propose that at least two unknown effectors regulate α3 mRNA levels in PC12 cells.